Veolia Korea signed a business agreement with Jeil Pharma to support its ESG management


Veolia signed a business agreement (10 yrs for energy performance & green power supply services + 10 yrs only for green power supply services) contract with Jeil Pharmaceutical to support its ESG management in October 2022. 

Veolia will provide low carbon solutions to Jeil Pharma, including the optimization of energy efficiency and production of green electricity at its production plant. The replacement of old facilities and installation of green energy generation facility is expected to reduce greenhouse gas emissions by more than 5% and save over 10% of energy costs. 

This is the second pharmaceutical project for Veolia Korea to provide its expertise and solutions to advance our client's ESG and sustainability goals.